Finding the Next Line of Treatment in Melanoma...Jeffrey Weber
| Published in: | Oncology (08909091) Vol. 34; no. 1; pp. 22 - 30 |
|---|---|
| Main Author: | |
| Format: | interview pictorial Journal Article |
| Published: |
MJH Life Sciences
Jan2020
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141641974&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 141641974 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08909091 YYT jtl: Oncology (08909091) issn: 08909091 maglogo: N pubinfo: dt: Jan2020 vid: 34 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 141641974 141641974 141641974 141641974 ppf: 22 ppct: 8 formats: fmt: @attributes: type: P tig: atl: Finding the Next Line of Treatment in Melanoma...Jeffrey Weber aug: au: Weber, Jeffrey affil: Deputy director of the Perlmutter Cancer Center and the codirector of the Melanoma Research Program at NYU Langone Health sug: subj: Melanoma Drug Therapy Immunotherapy Immune Checkpoint Inhibitors Therapeutic Use Antibodies, Monoclonal Therapeutic Use Recurrence Prevention and Control Tocilizumab Therapeutic Use Nivolumab Therapeutic Use Ipilimumab Therapeutic Use Toll-Like Receptors Therapeutic Use Protein Kinase Inhibitors Therapeutic Use Tyrosine Kinase Inhibitors Therapeutic Use T Lymphocytes Cell Therapy pubtype: Academic Journal doctype: interview pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|